Zacks Investment Research on MSN
Here is what to know beyond why Amgen Inc. (AMGN) is a trending stock
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...
Zacks Investment Research on MSN
Amgen (AMGN) laps the stock market: Here's why
In the latest trading session, Amgen (AMGN) closed at $349.69, marking a +1.43% move from the previous day. This move outpaced the S&P 500's daily gain of 0.5%. On the other hand, the Dow registered a ...
If you want to know who really controls Amgen Inc. (NASDAQ:AMGN), then you'll have to look at the makeup of its share ...
Amgen Inc (AMGN) reached a significant milestone as its stock hit a 52-week high of $346.41. This marks a notable point for the biotechnology company, reflecting a positive trend over the past year.
Amgen's (NASDAQ:AMGN) 11% CAGR outpaced the company's earnings growth over the same five-year period
If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...
Amgen (NASDAQ: AMGN) has outperformed the market over the past 15 years by 1.17% on an annualized basis producing an average annual return of 13.01%. Currently, Amgen has a market capitalization of ...
Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...
Amgen says its MariTide obesity drug helped patients maintain weight loss for a second year, with good safety and fewer side ...
Amgen's weight management candidate looks very promising. The large biotech boasts a deep pipeline beyond that segment. Amgen's dividend looks great, and the stock is reasonably valued. Even so, there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results